Search results for "Cardiovascular Disease"
LABAs, LAMAs for COPD may be associated with increased CVD risk in first 30 days of use
Study authors caution physicians to closely monitor new users of long-acting beta2-agonists (LABAs) or long-acting antimuscarinic antagonists (LAMAs) for cardiovascular symptoms.
https://immattersacp.org/weekly/archives/2018/01/09/4.htm
9 Jan 2018
Label change for pioglitazone-containing medications
This column reviews a label change for medicine that contain pioglitazone and a new indication for empagliflozin.
https://immattersacp.org/archives/2017/02/fda.htm
1 Feb 2017
Exercise a fitting path to improved health
Some physicians tout successes in getting patients moving more by suggesting incremental changes in their activity levels, and also by highlighting the more immediately visible payoffs.
https://immattersacp.org/archives/2021/04/exercise-a-fitting-path-to-improved-health.htm
1 Apr 2021
NAFLD treatment starts with weight loss, then other modes
Nonalcoholic fatty liver disease (NAFLD), which accounts for 30% to 40% of chronic liver disease in the U.S. today, is the hepatic manifestation of the metabolic syndrome and is associated with sleep apnea, cardiovascular disease, and diabetes.
https://immattersacp.org/archives/2016/07/NAFLD.htm
1 Jul 2016
Low-dose aspirin's effects on survival may come with caveats
A trial was stopped early after researchers determined that continued aspirin use appeared to yield no benefit.
https://immattersacp.org/weekly/archives/2018/09/18/2.htm
18 Sep 2018
Lack of access to PCSK9 inhibitors associated with cardiovascular events
Risk for myocardial infarction, unstable angina, acute ischemic heart disease, ischemic stroke, percutaneous coronary intervention, coronary artery bypass graft, and cardiac arrest was higher in patients whose prescription for a PCSK9 inhibitor was denied or abandoned.
https://immattersacp.org/weekly/archives/2019/07/30/2.htm
30 Jul 2019
Untreated white-coat hypertension associated with increased cardiovascular and mortality risk
An accompanying editorial suggested that out-of-office blood pressure monitoring be used to distinguish between white-coat hypertension and sustained hypertension in patients with high blood pressure measurements in the office.
https://immattersacp.org/weekly/archives/2019/06/11/1.htm
11 Jun 2019
USPSTF issues recommendations on statins for primary prevention
Among other recommendations, low- to moderate-dose statins should be started in adults 40 to 75 years of age who have no history of cardiovascular disease (CVD) but have at least 1 risk factor and a 10-year CVD event risk calculated at 10% or more.
https://immattersacp.org/weekly/archives/2016/11/22/1.htm
22 Nov 2016
USPSTF issues recommendations on statins for primary prevention
Among other recommendations, low- to moderate-dose statins should be started in adults 40 to 75 years of age who have no history of cardiovascular disease (CVD) but have at least 1 risk factor and a 10-year CVD event risk calculated at 10% or more.
https://immattersacp.org/weekly/archives/2016/11/15/1.htm
15 Nov 2016
Cardiac rehab uptake remains low, despite benefits
Estimates from the American Heart Association suggest that only about 20% to 30% of eligible patients ever receive the intervention.
https://immattersacp.org/archives/2022/03/cardiac-rehab-uptake-remains-low-despite-benefits.htm
1 Mar 2022